You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!
Enochian Biosciences, Inc. engages in the development of genetically modified cellular and immune-therapy technologies for treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Los Angeles, CA.
Los Angeles, California
52 Week High
52 Week Low